Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 NOV 26 ... TLR7 and TLR8 agonists, some of which can be attached to various proteins that enhances vaccine efficacy in a number of models. As small molecules, 3M's TLR7 and TLR8 agonists offer unique ...
2009 NOV 23 ... grants and contracts from the Department of Defense for development of a therapeutic vaccine for Hepatitis C, and from the National Institute of Allergy and Infectious Diseases (via ... which Aduro scientists have genetically engineered to enhance both safety and efficacy. Listeria is an ideal delivery platform to enable the human immune system to recognize a ...
2009 NOV 29 ... malaria because different tactics will work in different scenarios. In some places, a vaccine may work best, in more remote places, other low cost, low tech approaches will work ... can only be drawn so often, hindering researchers' ability to routinely monitor the efficacy of malarial drugs or vaccines."In areas like Southern Africa, we need a ...
2009 NOV 23 ... diseases of humans and animals. Mycobacterium bovis BCG, the only currently available TB vaccine, demonstrates variable levels of efficacy; therefore, a replacement or supplement to BCG ...
2009 NOV 23 ... Food and Drug Administration has approved the use of CSL Limited's 2009 H1N1 influenza vaccine to include children ages 6 months and older. This vaccine was previously approved only ... of the company's seasonal flu vaccine in children showing the vaccine's safety and efficacy in inducing antibodies to protect against influenza. These efficacy findings supported ...
2009 NOV 24 ... to understand why these differences in efficacy occur and what could be done to improve vaccine performance to maximize the life-saving benefits of vaccination." Patel ...
2009 NOV 29 ... vaccination rates varied widely across individual physicians (11-98 percent for PPV vaccine and 22-96 percent for influenza vaccine). They also found that longer reported ... in Family Medicine Practices Safe and Effective In a study validating the safety and efficacy of early abortion care by family physicians, researchers find the rates of complications ...
2009 NOV 23 ... Key epidemiological considerations in the postlicensure period include (1) how the vaccine will perform against severe rotavirus disease under routine public health use; (2) how ... States, "Two new vaccines against severe rotavirus gastroenteritis that have high efficacy in middle-and high-income countries have recently been licensed in many countries ...
2009 NOV 23 ... objective of this study was to demonstrate the efficacy of a modified-live virus (MLV) vaccine in protecting fetuses from infection with type 1 or type 2 Bovine viral diarrhea virus ...
2009 NOV 17 ... virus vaccines, thereby reducing the efficiency of infection or the efficacy of the vaccine." Kwilas and colleagues published their study in the Journal of Virology ...
2009 NOV 23 ... tumor infiltrating lymphocytes administered together with a highly immunogenic fowlpox vaccine expressing a gp100: 209-217 (210M) epitope," scientists writing in the Journal of ... study in the Journal of Immunotherapy (Impact of a Recombinant Fowlpox Vaccine on the Efficacy of Adoptive Cell Therapy With Tumor Infiltrating Lymphocytes in a Patient With ...
2009 NOV 23 ... and cellular immunology have paved the way toward the rational design of an efficacious vaccine. We exploited self-cleaving peptide 2A from the foot-and-mouth disease virus, because of ... According to a study from Berlin, Germany, "Concerns about the safety and efficacy of Mycobacterium bovis bacillus Calmette-Guerin (BCG) emphasize the need for alternative ...
2009 NOV 23 ... investigators in Copenhagen, Denmark report. "Additionally, we stratify vaccine efficacy by several baseline characteristics, including age, smoking status, and Papanicolaou ...
2009 NOV 24 ... for rotavirus gastroenteritis are needed to support the decision to introduce rotavirus vaccine in the Philippines. From 2005 through 2006, children aged <5 years with acute ... and is predominantly caused by strains against which current vaccines have shown good efficacy, suggesting that routine immunization will have a large impact on rotavirus disease ...
